TY - JOUR
T1 - QCT versus DXA in 320 survivors of childhood cancer
T2 - Association of BMD with fracture history
AU - Kaste, Sue C.
AU - Tong, Xin
AU - Hendrick, Jennifer M.
AU - Karimova, Evguenia J.
AU - Srivastava, Deo Kumar
AU - Tylavsky, Frances A.
AU - Snider, Terry L.
AU - Carbone, Laura D.
PY - 2006/12
Y1 - 2006/12
N2 - Purpose. To assess agreement on diagnosis of diminished bone mineral density (BMD) and correlation between BMD values obtained by dual-energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT) in childhood cancer survivors. Patients and Methods. We retrospectively reviewed lumbar spine QCT and DXA studies for BMD in patients who underwent both imaging studies within a 24-hr period. We determined correlation between BMD values and agreement on diagnosis of diminished BMD obtained by both modalities. Diminished BMD was defined as two or more SDs below mean for age- and gender-matched reference values. We evaluated the relationship of BMD values determined by each modality to self-reported fracture history in the 160 (50%) patients with available reports. Results. Of 320 patients, 56% (178) were male; 87% (277) were white. Median age was 16.4 (range, 5.1-36.0) years. Median BMD Z-score was -1.43 (range, -5.96 to 3.20) by QCT and -1.30 (range, -5.50 to 2.80) by DXA. Correlation between QCT- and DXA-determined BMD values was significant but low, and agreement on diminished BMD was fair (κ = 0.32). There was no association between BMD measured by either QCT or DXA and self-reported traumatic fracture history. Male gender was associated with doubling the traumatic fracture risk (P = 0.0499). Conclusions. Quantitative computed tomography and DXA may give discrepant results when used to assess bone health in childhood cancer survivors, especially in those of non-white race. This inconsistency in indicators of BMD deficiency may complicate clinical decision-making. Consecutive use of a single modality is recommended to provide reliable longitudinal information.
AB - Purpose. To assess agreement on diagnosis of diminished bone mineral density (BMD) and correlation between BMD values obtained by dual-energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT) in childhood cancer survivors. Patients and Methods. We retrospectively reviewed lumbar spine QCT and DXA studies for BMD in patients who underwent both imaging studies within a 24-hr period. We determined correlation between BMD values and agreement on diagnosis of diminished BMD obtained by both modalities. Diminished BMD was defined as two or more SDs below mean for age- and gender-matched reference values. We evaluated the relationship of BMD values determined by each modality to self-reported fracture history in the 160 (50%) patients with available reports. Results. Of 320 patients, 56% (178) were male; 87% (277) were white. Median age was 16.4 (range, 5.1-36.0) years. Median BMD Z-score was -1.43 (range, -5.96 to 3.20) by QCT and -1.30 (range, -5.50 to 2.80) by DXA. Correlation between QCT- and DXA-determined BMD values was significant but low, and agreement on diminished BMD was fair (κ = 0.32). There was no association between BMD measured by either QCT or DXA and self-reported traumatic fracture history. Male gender was associated with doubling the traumatic fracture risk (P = 0.0499). Conclusions. Quantitative computed tomography and DXA may give discrepant results when used to assess bone health in childhood cancer survivors, especially in those of non-white race. This inconsistency in indicators of BMD deficiency may complicate clinical decision-making. Consecutive use of a single modality is recommended to provide reliable longitudinal information.
KW - Bone density
KW - Childhood cancer
KW - DXA
KW - Quantitative computed tomography (QCT)
UR - http://www.scopus.com/inward/record.url?scp=33750462382&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33750462382&partnerID=8YFLogxK
U2 - 10.1002/pbc.20854
DO - 10.1002/pbc.20854
M3 - Review article
C2 - 16602115
AN - SCOPUS:33750462382
SN - 1545-5009
VL - 47
SP - 936
EP - 943
JO - Pediatric Blood and Cancer
JF - Pediatric Blood and Cancer
IS - 7
ER -